Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Arrhythmias

Free Subscription 20.07.2026 1 Am J Cardiol 1 Circ Cardiovasc Interv 2 Eur Heart J 1 Heart 2 Int J Cardiol 1 J Am Coll Cardiol 14 J Cardiovasc Electrophysiol 2 J Emerg Med 1 J Interv Card Electrophysiol 2 Lancet 1 Pacing Clin Electrophysiol 2 PLoS One 1 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. SCALIA L, Gatto L, Agnello F, Calderone D, et al
   Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population.
   Am J Cardiol. 2026 Jul 14:S0002-9149(26)00445.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

2. JEON HK, Jeon HS, Lee K, Cho YH, et al
   Antithrombotic Therapy in Patients With Atrial Fibrillation With Prior Complex PCI: A Secondary Analysis of the Randomized ADAPT AF-DES Trial.
   Circ Cardiovasc Interv. 2026 Jul 17:e016841.
   PubMed         Abstract available
   
   

   
   Eur Heart J

3. PERIN F, Carton AJ, Bermudez-Jimenez FJ, Fernandez-Barrio BC, et al
   Paediatric long QT syndrome: clinical outcomes and therapy in the Spanish National Registry.
   Eur Heart J. 2026 Jul 17:ehag513. doi: 10.1093.
   PubMed         Abstract available
   
   
4. FAUCHIER L, Guglieri M, Lenormand T, Bisson A, et al
   Influenza vaccination, incident atrial fibrillation, and cardiovascular outcomes.
   Eur Heart J. 2026 Jul 11:ehag543. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Heart

5. BRANDES A
   Private versus public hospital care after emergency admission for atrial fibrillation: a call for optimising atrial fibrillation care.
   Heart. 2026 Jul 15:heartjnl-2026-328575. doi: 10.1136/heartjnl-2026-328575.
   PubMed        
   
   

   
   Int J Cardiol

6. EGAMI Y, Matsubara H, Muroya R, Nagai K, et al
   ALID score for treatment-effect heterogeneity of adjunctive low-voltage area ablation in persistent atrial fibrillation: A post hoc analysis of SUPPRESS-AF.
   Int J Cardiol. 2026 Jul 16:134674. doi: 10.1016/j.ijcard.2026.134674.
   PubMed         Abstract available
   
   
7. MOSER ED, He R, Wang W, Van't Hof JR, et al
   Atrial myopathy subtypes: Association with and prediction of incident atrial fibrillation-The atherosclerosis risk in communities study (ARIC).
   Int J Cardiol. 2026;461:134667.
   PubMed         Abstract available
   
   

   
   J Am Coll Cardiol

8. SHEN Y, Guo X, Zeng C, Wang DW, et al
   Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study.
   J Am Coll Cardiol. 2026 Feb 25:S0735-1097(26)00233.
   PubMed         Abstract available
   
   

   
   J Cardiovasc Electrophysiol

9. PANG N, Cao Z, Tao Y, Wang Y, et al
   Identifying Driver Regions in Persistent Atrial Fibrillation: A Mosaic Pattern Within the Atrial Voltage Transition Zone.
   J Cardiovasc Electrophysiol. 2026 Jul 16. doi: 10.1111/jce.70451.
   PubMed         Abstract available
   
   
10. ZOR SM, Hoeksema W, Baselmans B, Kemme MJB, et al
    Dominant Frequency Mapping as a Functional Tool for Substrate-Guided Ventricular Tachycardia Ablation.
    J Cardiovasc Electrophysiol. 2026;37:1399-1409.
    PubMed         Abstract available
    
    
11. DELL'ERA G, Palmisano P, Dugo D, Spera FR, et al
    Impact of Left Bundle Branch Area Pacing on Echocardiographic Parameters and Symptoms: Data From the Conduction System Pacing Italian Network Group (C-SING) Study.
    J Cardiovasc Electrophysiol. 2026;37:1432-1441.
    PubMed         Abstract available
    
    
12. YOGARAJAH J, Dannebaum J, Halim A, Sedighi J, et al
    Prevalence and Recovery of Arrhythmia-Induced Cardiomyopathy in Patients With Newly Diagnosed Heart Failure Using a Wearable Defibrillator: A Real-World Cohort Study.
    J Cardiovasc Electrophysiol. 2026;37:1465-1475.
    PubMed         Abstract available
    
    
13. MORGAN AA, Adhikari S, Alper A, Faillace R, et al
    Real-World Adverse Events Associated With the Sphere-9 Dual-Energy Arrhythmia Ablation Catheter.
    J Cardiovasc Electrophysiol. 2026;37:1476-1481.
    PubMed         Abstract available
    
    
14. SCIACCA V, Retzlaff J, Braun M, Fink T, et al
    Implementation of a Standardized Nurse-Guided Heparinization Protocol Improves Anticoagulation During Left Atrial Ablation Procedures.
    J Cardiovasc Electrophysiol. 2026;37:1504-1513.
    PubMed         Abstract available
    
    
15. NAZMY A, El-Shirbiny H, Abouelmagd AA, Hammad N, et al
    Mechanical Circulatory Support During Ventricular Tachycardia Ablation: A Systematic Review and Meta-Analysis of Procedural and Clinical Outcomes.
    J Cardiovasc Electrophysiol. 2026;37:1564-1576.
    PubMed         Abstract available
    
    
16. FONSECA IMG, Franca AT, Carmo AALD, van der Crabben SN, et al
    Successful Use of Ranolazine in SCN5A p.R222Q-Related Multifocal Ectopic Purkinje-Related Premature Contractions.
    J Cardiovasc Electrophysiol. 2026;37:1618-1622.
    PubMed         Abstract available
    
    
17. AGARWAL S, Patel HP, Patil S, Gupta A, et al
    Long-Term Outcomes of Leadless Pacemaker vs. Transvenous Pacemaker in End-Stage Renal Disease.
    J Cardiovasc Electrophysiol. 2026;37:1599-1604.
    PubMed         Abstract available
    
    
18. HANNA D, Rodriguez B, Grabarczyk G, PerezHernandez J, et al
    Safety and Feasibility of Dual-Energy Lattice-Tip Catheter for Cavotricuspid Isthmus Ablation in Patients With Cardiac Implantable Electronic Devices: A Single-Center Experience.
    J Cardiovasc Electrophysiol. 2026;37:1592-1598.
    PubMed         Abstract available
    
    
19. CECCO D, de Lavallaz JDF, Huang HD, Kovacs B, et al
    Intracardiac Echocardiography and Coronary Angiography During Ventricular Ablation From the Aortic Cusps and Commissures: Marked Inter-Center Variability Without an Observed Coronary Injury Signal.
    J Cardiovasc Electrophysiol. 2026;37:1607-1610.
    PubMed         Abstract available
    
    
20. ONUKI K, Hiroshima K, Isotani A, Fukunaga M, et al
    A Simplified Epicardial Ablation Strategy for Ventricular Tachycardia Integrating CT-Derived Epicardial Adipose Tissue Into Three-Dimensional Electroanatomic Mapping.
    J Cardiovasc Electrophysiol. 2026;37:1623-1626.
    PubMed         Abstract available
    
    
21. TURRENI F, Santini L, Loricchio ML, Castro A, et al
    Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD-Guided Intervention.
    J Cardiovasc Electrophysiol. 2026;37:1577-1587.
    PubMed         Abstract available
    
    
22. CANOVI L, Melpignano A, Malagu M, Balla C, et al
    Impact of Left Bundle Branch Pacing on Left Ventricular Mechanical Efficiency.
    J Cardiovasc Electrophysiol. 2026;37:1554-1563.
    PubMed         Abstract available
    
    

    
    J Emerg Med

23. OZATAK AT, Sonmez E, Ozatak P, Ozcan AB, et al
    Predictors of Adenosine-Induced Sinus Pause Duration for Supraventricular Tachycardia in the Emergency Department: The Role of Body Mass Index and Symptom Duration.
    J Emerg Med. 2026;87:122-130.
    PubMed         Abstract available
    
    
24. GERMANY JL, Cabrejas J, Ross S, Eilbert W, et al
    Ventricular Tachycardia Terminated by Vagal Maneuvers.
    J Emerg Med. 2026;87:118-121.
    PubMed         Abstract available
    
    

    
    J Interv Card Electrophysiol

25. LORENTE-ROS M, Kerley R, Keane D, Hadadi C, et al
    Pulsed field ablation for pulmonary vein isolation with or without posterior wall ablation in patients with persistent atrial fibrillation: a multicenter study.
    J Interv Card Electrophysiol. 2026 Jul 13. doi: 10.1007/s10840-026-02402.
    PubMed         Abstract available
    
    

    
    Lancet

26. LIP GYH, Kuzma L
    Combination antithrombotic therapy in atrial fibrillation after coronary interventions: shorter duration, more safety?
    Lancet. 2026 Jul 15:S0140-6736(26)00747-6. doi: 10.1016/S0140-6736(26)00747.
    PubMed        
    
    
27. SOTOMI Y, Kozuma K, Higuchi Y, Nakazawa G, et al
    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.
    Lancet. 2026 Jul 15:S0140-6736(26)00665-3. doi: 10.1016/S0140-6736(26)00665.
    PubMed         Abstract available
    
    

    
    Pacing Clin Electrophysiol

28. TACHIBANA S, Miyazaki S, Nitta J, Yamashita S, et al
    Phrenic Nerve Injury After Catheter Ablation for Atrial Fibrillation.
    Pacing Clin Electrophysiol. 2026 Jul 16. doi: 10.1111/pace.70360.
    PubMed         Abstract available
    
    

    
    PLoS One

29. OKPALAORA CS, Young SW, Lee TA
    The pharmacist's role in the periprocedural management of anticoagulation in Canada: A qualitative study protocol.
    PLoS One. 2026;21:e0353786.
    PubMed         Abstract available
    
    
30. KAKEI Y, Senoo K, Yukawa A, Kawai K, et al
    Rates and predictors of hospital visits after "Possible AF" alerts from a home ECG monitor in older adults with hypertension: A sub-analysis of the Omron Heart Study.
    PLoS One. 2026;21:e0353867.
    PubMed         Abstract available
    
    

    
    Stroke

31. WANG L, Lin F, Chen Y, Liang X, et al
    Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation.
    Stroke. 2026 Jul 17. doi: 10.1161/STROKEAHA.125.054141.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum